INDUSTRY NEWS Lycera Achieves $11 Million Second Tranche in Series A Financing Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. [Lycera Corp. Press Release] Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter Bristol-Myers Squibb posted first quarter 2010 net sales of $4.8 billion, an increase of 11%, or 8% excluding foreign exchange impact, compared to the same period in 2009. [Bristol-Myers Squibb Co. Press Release] TxCell Announces Positive Preliminary Results from the Phase I/IIa Clinical Trial of OvaSave in Crohn’s Disease TxCell SA, a French biotechnology company developing autologous cell-based therapies using Type 1 T-regulatory lymphocytes (Tr1) for the treatment of chronic inflammatory and autoimmune diseases, announced positive preliminary results from the ongoing Phase I/IIa clinical trial regarding OvaSave(R), an investigational new drug, in patients with severe and refractory Crohn’s disease. [TxCell SA Press Release] New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of Multiple Sclerosis Teva Pharmaceutical Industries Ltd. and Active Biotech announced results from several studies demonstrating that laquinimod, a novel, investigational once-daily oral immunomodulator for relapsing remitting multiple sclerosis (RRMS) may have neuroprotective properties in addition to its anti-inflammatory effects. [The Wall Street Journal]
|
|
POLICY NEWS Gubernatorial Candidates Talk Ways to Boost Bioscience Five gubernatorial candidates offered their prescriptions for creating a healthier climate for Minnesota’s biotech industry that included lower taxes, higher government spending, and faith in science over ideology. [Minnesota, United States] Request for Information (RFI): Priorities for the NIH Adherence Research Network (NOT-OD-10-078) [National Institutes of Health, United States] Waivers for Conflicts of Interest for the May 7, 2010 Vaccines and Related Biological Products Advisory Committee Meeting [Food and Drug Administration, United States] FDA Announces Draft Revised Guidance on Transparency and Advisory Committees [Food and Drug Administration, United States] Draft Guidance for the Public, Food and Drug Administration Advisory Committee Members, and Food and Drug Administration Staff: Public Availability of Advisory Committee Members’ Financial Interest Information and Waivers; Availability (Docket No. FDA-2002-D-0094) [Food and Drug Administration, United States]
|
|
EVENTS 97th Annual Meeting of the American Association of Immunologists (AAI) May 7-11, 2010 Baltimore, United States 29th Congress of the European Academy of Allergy and Clinical Immunology (EAACI) June 5-9, 2010 London, United Kingdom Keystone Symposia: Innate Immunity – Mechanisms Linking with Adaptive Immunity (D3) June 7-12, 2010 Dublin, Ireland Federation of Clinical Immunology Societies (FOCIS) 2010 June 24-27, 2010 Boston, United States Frontiers in Immunology Research (FIRN) 2010 International Conference July 22-26, 2010 Athens, Greece 14th International Congress of Immunology August 22-27, 2010 Kobe, Japan Select BioSciences 7th Annual RNAi & miRNA Europe September 14-15, 2010 Dublin, Ireland 5th International Conference on Gene Regulation in Lymphocyte Development October 9-14, 2010 Chania, Greece Autumn Immunology Conference 2010 November 19-22, 2010 Chicago, United States Cell Symposia: Influenza – Translating Basic Insights December 2-4, 2010 Washington, D.C., United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Sr. Product Support and Training Specialist (CardianBCT) Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities.
Have we missed an important article or publication in Immune Regulation News? Click here to submit!
|
| |
|